Clinical Laboratories Should Anticipate Increased Supply Chain Disruptions as Demand for SARS-CoV-2 Diagnostic Testing Grows
Large diagnostic clinical laboratories publicly share pain of surge in COVID-19 test demand. Recent lab pro letter urges “visibility into the process of supply allocation.” Smaller labs may be getting shortchanged.